five

DataSheet_1_Prevalence of somatic diseases in adults with attention deficit hyperactivity disorder in Japan is highest in people aged ≥40 years with mental disorders: a cross-sectional study of a Japanese health insurance claims database.docx

收藏
frontiersin.figshare.com2024-02-14 更新2025-03-26 收录
下载链接:
https://frontiersin.figshare.com/articles/dataset/DataSheet_1_Prevalence_of_somatic_diseases_in_adults_with_attention_deficit_hyperactivity_disorder_in_Japan_is_highest_in_people_aged_40_years_with_mental_disorders_a_cross-sectional_study_of_a_Japanese_health_insurance_claims_database_docx/25216502/1
下载链接
链接失效反馈
官方服务:
资源简介:
IntroductionStudies have reported an association between attention deficit hyperactivity disorder (ADHD) and somatic diseases; however, the correlation of mental disorders with the association between ADHD and somatic diseases remains uninvestigated. This study investigated and compared the prevalence of somatic diseases among adults with/without ADHD, stratified by the presence or absence of mental disorders.MethodsThis cross-sectional study (October 2020–September 2021), using data (June 2013–September 2021) from a Japanese health insurance claims database, included adult participants with a medical record of and receiving medication for ADHD (ADHD group); the control group (matched 1:5 by age/sex) comprised participants without ADHD. The prevalence and odds ratio (OR; ADHD versus control) of type 2 diabetes mellitus (T2DM), diabetes complications, hypertension, cardiovascular disease (CVD), dyslipidemia, gout and hyperuricemia, chronic obstructive pulmonary disease (COPD), non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH), and atopic dermatitis were investigated. Pooled ORs for stratified analysis were calculated using the Mantel-Haenszel method.ResultsIn the matched analysis sets, the ORs for all somatic diseases were significantly higher for the ADHD group (n=15,028) versus the control group (n=74,796). On stratified analysis, the Mantel-Haenszel ORs were significant for NAFLD/NASH (1.53; 95% confidence interval [CI]: 1.34, 1.73), diabetes complications (1.39; 95% CI: 1.09, 1.77), and gout and hyperuricemia (1.34; 95% CI: 1.19, 1.51). Furthermore, the stratum-specific ORs for T2DM, hypertension, and dyslipidemia were >1 and

研究文献指出,注意缺陷多动障碍(ADHD)与躯体疾病之间存在关联;然而,精神障碍与ADHD与躯体疾病之间关联的相关性尚未得到探讨。本研究旨在调查并比较患有/未患有ADHD的成年人中躯体疾病的患病率,并按是否存在精神障碍进行分层。方法:本项横断面研究(2020年10月至2021年9月),利用来自日本医疗保险索赔数据库的数据(2013年6月至2021年9月),纳入了具有ADHD医疗记录并接受ADHD药物治疗(ADHD组)的成年参与者;对照组(按年龄/性别匹配1:5)由无ADHD的参与者组成。调查了2型糖尿病(T2DM)、糖尿病并发症、高血压、心血管疾病(CVD)、血脂异常、痛风和高尿酸血症、慢性阻塞性肺疾病(COPD)、非酒精性脂肪性肝病/非酒精性脂肪性肝炎(NAFLD/NASH)和特应性皮炎的患病率和比值比(OR;ADHD组与对照组相比)。使用Mantel-Haenszel方法计算分层分析的汇总OR值。结果:在匹配分析集中,与对照组(n=74,796)相比,ADHD组(n=15,028)所有躯体疾病的OR值均显著升高。在分层分析中,Mantel-Haenszel OR值对NAFLD/NASH(1.53;95%置信区间[CI]:1.34, 1.73)、糖尿病并发症(1.39;95% CI:1.09, 1.77)和痛风及高尿酸血症(1.34;95% CI:1.19, 1.51)均有统计学意义。此外,T2DM、高血压和血脂异常的层析特定OR值均大于1。
提供机构:
frontiersin.figshare.com
二维码
社区交流群
二维码
科研交流群
商业服务